Literature DB >> 10794635

Effects of tea polyphenols on the invasion and matrix metalloproteinases activities of human fibrosarcoma HT1080 cells.

M Maeda-Yamamoto1, H Kawahara, N Tahara, K Tsuji, Y Hara, M Isemura.   

Abstract

The effects of tea polyphenols on the invasion of highly metastatic human fibrosarcoma HT1080 cells through a monolayer of human umbilical vein endothelial cells (HUVECs) and the accompanying basal membrane were investigated. Among the tea polyphenols tested, epicatechin gallate (ECg), epigallocatechin gallate (EGCg), and theaflavin strongly suppressed the invasion of HT1080 cells into the monolayer of HUVECs/gelatin membrane, whereas epicatechin, epigallocatechin, tea flavonols, tea flavones, and gallate derivatives had no effect. Both theaflavin-digallate and theasinensin D showed a weak invasion inhibitory effect. ECg significantly inhibited the invasion without cytotoxicity against cancer cells and HUVECs. Ester-type catechins (ECg and EGCg) and theaflavin strongly suppressed the gelatin degradation mediated by matrix metalloproteinase (MMP) 2 and MMP-9, which were secreted into the conditioned medium of HT1080 cells. In conclusion, among the tea polyphenols tested, ECg was considered to be the agent with the most potential antimetastasis activity because it inhibited invasion in the absence of cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10794635     DOI: 10.1021/jf9811525

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  16 in total

1.  Effect of green tea powder (Camellia sinensis L. cv. Benifuuki) particle size on O-methylated EGCG absorption in rats; The Kakegawa Study.

Authors:  Mari Maeda-Yamamoto; Kaori Ema; Yoshiko Tokuda; Manami Monobe; Hirofumi Tachibana; Yoichi Sameshima; Shinichi Kuriyama
Journal:  Cytotechnology       Date:  2011-01-05       Impact factor: 2.058

Review 2.  Inhibition of tumour invasion and angiogenesis by epigallocatechin gallate (EGCG), a major component of green tea.

Authors:  Y D Jung; L M Ellis
Journal:  Int J Exp Pathol       Date:  2001-12       Impact factor: 1.925

3.  In vivo and in vitro antitumor effect of ascorbic acid, lysine, proline, arginine, and green tea extract on human fibrosarcoma cells HT-1080.

Authors:  M Waheed Roomi; Vadim Ivanov; Tatiana Kalinovsky; Aleksandra Niedzwiecki; Matthias Rath
Journal:  Med Oncol       Date:  2006       Impact factor: 3.064

4.  Tea catechin auto-oxidation dimers are accumulated and retained by Caco-2 human intestinal cells.

Authors:  Andrew P Neilson; Brian J Song; Teryn N Sapper; Joshua A Bomser; Mario G Ferruzzi
Journal:  Nutr Res       Date:  2010-05       Impact factor: 3.315

Review 5.  The chemopreventive and chemotherapeutic potentials of tea polyphenols.

Authors:  Vijay S Thakur; Karishma Gupta; Sanjay Gupta
Journal:  Curr Pharm Biotechnol       Date:  2012-01       Impact factor: 2.837

6.  The modulation of endothelial cell gene expression by green tea polyphenol-EGCG.

Authors:  Liping Liu; Chao-Qiang Lai; Lin Nie; Jose Ordovas; Michael Band; Leta Moser; Mohsen Meydani
Journal:  Mol Nutr Food Res       Date:  2008-10       Impact factor: 5.914

7.  Potent inhibitors of anthrax lethal factor from green tea.

Authors:  Isabella Dell'Aica; Massimo Donà; Fiorella Tonello; Alejandro Piris; Michèle Mock; Cesare Montecucco; Spiridione Garbisa
Journal:  EMBO Rep       Date:  2004-03-12       Impact factor: 8.807

8.  In vitro and in vivo anti-allergic effects of 'benifuuki' green tea containing O-methylated catechin and ginger extract enhancement.

Authors:  Mari Maeda-Yamamoto; Kaori Ema; Ikuo Shibuichi
Journal:  Cytotechnology       Date:  2007-11-25       Impact factor: 2.058

Review 9.  Health-promoting effects of green tea.

Authors:  Yasuo Suzuki; Noriyuki Miyoshi; Mamoru Isemura
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2012       Impact factor: 3.493

10.  Epicatechins Purified from Green Tea (Camellia sinensis) Differentially Suppress Growth of Gender-Dependent Human Cancer Cell Lines.

Authors:  Mepur H Ravindranath; Thiruverkadu S Saravanan; Clarence C Monteclaro; Naftali Presser; Xing Ye; Senthamil R Selvan; Stanley Brosman
Journal:  Evid Based Complement Alternat Med       Date:  2006-04-25       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.